Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Enhanced stem cells from the placenta can help treat Graves' eye disease by stopping fat cell growth.

GRF is not safe for tubal occlusion.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Peripheral nerve blocks are a safe and effective way to treat various headaches and provide lasting pain relief.

Geranylgeraniol from nutmeg may effectively treat hair loss, similar to finasteride and better than minoxidil.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Mutations in certain receptors can cause diseases and offer new treatment options.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Neuroendocrine paraneoplastic syndromes often show skin changes, helping early diagnosis and requiring a team approach for best care.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Glycyrrhizin may help regrow hair by activating a specific pathway.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Neurotrophins, especially NGF, are crucial for pain development and management.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe side effects.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Activating the GDNF-GFRα1-RET signaling pathway could potentially promote skin and limb regeneration in humans and could be used to treat hair loss and promote wound healing.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.